Newsroom

Currently, the bronchiolitis epidemic is globally accelerating and worsening. This common lung infection affects essentially young infants provoking coughs and difficulties in breathing and increases the risk of hospitalization in intensive units and/or the length of stay in hospitals and children.

An independent study has shown that Laboratoires SMB’s Axahaler has a superior delivered dose when compared to other devices. The Fine Particle Dose, the respirable dose critical

Laboratoires S.M.B.S.A. is the first company that has successfully concluded a study to show that its Vitamin D product positively impacts the clinical outcome of hospitalized COVID-19 patients.